APA (7th ed.) Citation

Gooderham, M., Guttman-Yassky, E., Igawa, K., Kabashima, K., Esfandiari, E., Rylands, A. J., . . . Simpson, E. (2024). Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study. Dermatology and therapy, 14(12), 3351-3366. https://doi.org/10.1007/s13555-024-01303-z

Chicago Style (17th ed.) Citation

Gooderham, Melinda, et al. "Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study." Dermatology and Therapy 14, no. 12 (2024): 3351-3366. https://doi.org/10.1007/s13555-024-01303-z.

MLA (9th ed.) Citation

Gooderham, Melinda, et al. "Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study." Dermatology and Therapy, vol. 14, no. 12, 2024, pp. 3351-3366, https://doi.org/10.1007/s13555-024-01303-z.